AbbVie | ABBV - Capitalización De Mercado

Precio De Mercado
209.40
Cambio Diario
-1.72 -0.81%
Mensual
-10.61%
Anual
2.00%
Q1 Expectativa
203.12




Capitalización De Mercado Cambio Fecha
AbbVie USD 403.83B 5.2B 2025-12
Abbott USD 217.86B 15.25B 2025-12
ALKERMES USD 4.47B 146M 2026-03
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 183M 11M 2026-03
Eisai JPY 1.4T 85.07B 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Infinity Pharmaceuticals USD 19M 5M 2023-06
J&J USD 500.24B 67.44B 2025-12
Medtronic USD 105.26B 24.07B 2026-03
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.4B 520M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
UCB EUR 47.65B 1.24B 2026-03
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Zoetis USD 55.45B 9.4B 2025-12